CHICAGO — A real-world study of the ocular side effects of the gynecological cancer treatment mirvetuximab (Elahere) has found more than two of three women taking the drug experienced some type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback